Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigenpresenting cells

Mucosal Immunology

Volumn 7, Issue 3, 2014, Pages 670-683

  Jeyanathan, M ^a,b   McCormick, S ^a,b   Lai, R ^a,b   Afkhami, S ^a,b   RShaler, C ^a,b   Horvath, C N ^b   Damjanovic, D ^a,b   Zganiacz, A ^a,b   Barra, N ^a,b   Ashkar, A ^a,b   Jordana, M ^a   Aoki, N ^a   Xing, Z ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 10; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; AUTACOID; CYTOKINE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK3 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROBP PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; IMMUNOPHENOTYPING; INFECTION PREVENTION; INNATE IMMUNITY; LUNG TUBERCULOSIS; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; ANIMAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-10; LUNG; LYMPHOCYTE ACTIVATION; MALE; MICE; MYCOBACTERIUM TUBERCULOSIS; NF-KAPPA B; SIGNAL TRANSDUCTION; TH1 CELLS; TUBERCULOSIS, PULMONARY;

EID: 84899547413     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.86     Document Type: Article

References (63)

1. WHO. Global Tuberculosis Report 2012 (2012).
2. Jeyanathan, M, Heriazon, A & Xing, Z. Airway luminal T cells: a newcomer on the stage of TB vaccination strategies. Trends Immunol. 31, 247-252 (2010).
3. Ottenhoff, T.H. & Kaufmann, S.H. Vaccines against tuberculosis: where are we and where do we need to go?. PLoS Pathog. 8, e1002607 (2012).
4. Flynn, J.L., Chan, J & Lin, P.L. Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol. 4, 271-278 (2011).
5. McCormick, S, Shaler,C.R. & Xing, Z. Pulmonary mucosal dendritic cells in T-cell activation: implications for TB therapy. Expert Rev. Respir. Med. 5, 75-85 (2011).
6. Cooper, A.M. & Khader, S.A. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 226, 191-204 (2008).
7. Chackerian, A.A., Perera, T.V. & Behar, S.M. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect. Immun. 69, 2666-2674 (2001).
8. Chackerian, A.A., Alt, J.M., Perera, T.V., Dascher, C.C. & Behar, S.M. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70, 4501-4509 (2002).
9. Reiley, W.W. et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc. Natl. Acad. Sci. USA 105, 10961-10966 (2008).
10. Wolf, A.J. et al. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 205, 105-115 (2008).
11. Horvath, C.N., Shaler, C.R., Jeyanathan, M, Zganiacz, A & Xing, Z. Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: a critical role of airway luminal T cells. Mucosal Immunol. 5, 420-431 (2012).
12. Cooper, A.M. T cells in mycobacterial infection and disease. Curr. Opin. Immunol. 21, 378-384 (2009).
13. North, R.J. & Jung, Y.J. Immunity to tuberculosis. Annu. Rev. Immunol. 22, 599-623 (2004).
14. Urdahl, K.B., Shafiani, S & Ernst, J.D. Initiation and regulation of T-cell responses in tuberculosis. Mucosal Immunol. 4, 288-293 (2011).
15. Shaler, C.R., Horvath, C, Lai, R & Xing, Z. Understanding delayed T-cell priming, lung recruitment, and airway luminal T-cell responses in host defense against pulmonary tuberculosis. Clin. Dev. Immunol. 2012, 628293 (2012).
16. Blomgran, R, Desvignes, L, Briken, V & Ernst, J.D. Mycobacterium tuberculosis inhibits neutrophil apoptosis, leading to delayed activation of naive CD4 T cells. Cell Host Microbe 11, 81-90 (2012).
17. Divangahi, M, Desjardins, D, Nunes-Alves, C, Remold, H.G. & Behar, S.M. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat. Immunol. 11, 751-758 (2010).
18. Shafiani, S, Tucker-Heard, G, Kariyone, A, Takatsu, K & Urdahl, K.B. Pathogen-specific regulatory Tcells delay the arrival of effector Tcells in the lung during early tuberculosis. J. Exp. Med. 207, 1409-1420 (2010).
19. Wolf, A.J. et al. Mycobacterium tuberculosis infects dendritic cellswith high frequency and impairs their function in vivo. J. Immunol. 179, 2509-2519 (2007).
20. Aoki, N, Kimura, S & Xing, Z. Role of DAP12 in innate and adaptive immune responses. Curr. Pharm. Des. 9, 7-10 (2003).
21. Turnbull, I.R. & Colonna, M. Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 7, 155-161 (2007).
22. Lanier, L.L. DAP10-and DAP12-associated receptors in innate immunity. Immunol. Rev. 227, 150-160 (2009).
23. Hamerman, J.A., Ni, M, Killebrew, J.R., Chu, C.L. & Lowell, C.A. The expanding roles of ITAM adapters FcRgamma and DAP12 inmyeloid cells. Immunol. Rev. 232, 42-58 (2009).
24. Bouchon, A, Facchetti, F, Weigand,M.A. & Colonna,M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410, 1103-1107 (2001).
25. Hamerman, J.A., Tchao, N.K., Lowell, C.A. & Lanier, L.L. Enhanced Tolllike receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 6, 579-586 (2005).
26. Hamerman, J.A., Jarjoura, J.R., Humphrey, M.B., Nakamura, M.C., Seaman, W.E. & Lanier, L.L. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177, 2051-2055 (2006).
27. French, A.R. et al. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J. Immunol. 177, 4981-4990 (2006).
28. Turnbull, I.R. et al. Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177, 3520-3524 (2006).
29. Divangahi, M. et al. Critical negative regulation of type 1 Tcell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection. J. Immunol. 179, 4015-4026 (2007).
30. N'Diaye,E.N. et al.TREM-2 (triggering receptorexpressed onmyeloid cells 2) is a phagocytic receptor for bacteria. J. Cell. Biol. 184, 215-223 (2009).
31. McCormick, S. et al. Control of pathogenic CD4 T cells and lethal immunopathology by signaling immunoadaptor DAP12 during influenza infection. J. Immunol. 187, 4280-4292 (2011).
32. Sumpter, T.L., Packiam, V, Turnquist, H.R., Castellaneta, A, Yoshida, O & Thomson, A.W. DAP12 promotes IRAK-M expression and IL-10 production by liver myeloid dendritic cells and restrains their T cell allostimulatory ability. J. Immunol. 186, 1970-1980 (2011).
33. Aoki, N, Zganiacz, A, Margetts, P & Xing, Z.Differential regulation ofDAP12 and molecules associated with DAP12 during host responses to mycobacterial infection. Infect. Immun. 72, 2477-2483 (2004).
34. Cooper, A.M. Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27, 393-422 (2009).
35. Wakeham, J, Wang, J & Xing, Z. Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL/6 and BALB/c mice. Infect. Immun. 68, 6946-6953 (2000).
36. Zganiacz, A. et al. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 113, 401-413 (2004).
37. de la Barrera, S. et al. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin. Exp. Immunol. 138, 128-138 (2004).
38. Redford, P.S. et al. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur. J. Immunol. 40, 2200-2210 (2010).
39. Redford, P.S., Murray, P.J. & O'Garra, A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 4, 261-270 (2011).
40. Shaler, C.R. et al. Pulmonary mycobacterial granuloma increased IL-10 production contributes to establishing a symbiotic host-microbe microenvironment. Am. J. Pathol. 178, 1622-1634 (2011).
41. Kobayashi, K, Hernandez, L.D., Galan, J.E., Janeway, C.A. Jr, Medzhitov, R & Flavell, R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202 (2002).
42. Flannery, S & Bowie, A.G. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. Biochem. Pharmacol. 80, 1981-1991 (2010).
43. Cole, T.S. et al. IRAK-M modulates expression of IL-10 and cell surface markers CD80 and MHC II after bacterial re-stimulation of tolerized dendritic cells. Immunol. Lett. 144, 49-59 (2012).
44. Matsunaga, K, Klein, T.W., Friedman, H & Yamamoto, Y. Alveolar macrophage cell line MH-S is valuable as an in vitro model for Legionella pneumophila infection. Am. J. Respir. Cell Mol. Biol. 24, 326-331 (2001).
45. Sendide, K,Deghmane,A.E., Pechkovsky,D,Av-Gay,Y, Talal,A & Hmama, Z. Mycobacterium bovis BCG attenuates surface expression of mature class II molecules through IL-10-dependent inhibition of cathepsin S. J. Immunol. 175, 5324-5332 (2005).
46. Jacobs, M, Fick, L, Allie, N, Brown, N & Ryffel, B. Enhanced immune response in Mycobacterium bovis bacille calmette guerin (BCG)-infected IL-10-deficient mice. Clin. Chem. Lab. Med. 40, 893-902 (2002).
47. Jeyanathan, M. et al. Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmidDNA tuberculosis vaccination: role of proinflammatory signals in the lung. J. Immunol. 181, 5618-5626 (2008).
48. Kohlmeier, J.E. et al. The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 29, 101-113 (2008).
49. Beisiegel, M. et al. Combination of host susceptibility and virulence of Mycobacterium tuberculosis determines dual role of nitric oxide in the protection and control of inflammation. J. Infect.Dis. 199, 1222-1232 (2009).
50. Myers, A.J., Marino, S, Kirschner, D.E. & Flynn, J.L. Inoculation dose of Mycobacterium tuberculosis does not influence priming of Tcell responses in lymph nodes. J. Immunol. 190, 4707-4716 (2013).
51. Torrelles, J.B. & Schlesinger, L.S. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb) 90, 84-93 (2010).
52. Pathak, S.K., Basu, S, Bhattacharyya, A, Pathak, S, Kundu, M & Basu, J. Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages. J. Biol. Chem. 280, 42794-42800 (2005).
53. Almeida, A.S. et al. Tuberculosis is associated with a down-modulatory lung immune response that impairs Th1-type immunity. J. Immunol. 183, 718-731 (2009).
54. Bonecini-Almeida, M.G. et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGFbeta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect. Immun. 72, 2628-2634 (2004).
55. Jamil, B. et al. Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb) 87, 279-287 (2007).
56. Nochi, H. et al. Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig molecules. Am. J. Pathol. 162, 1191-1201 (2003).
57. Turnis, M.E. et al. IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity. J. Immunol. 185, 4223-4232 (2010).
58. Norton, J.T., Hayashi, T, Crain, B, Corr, M & Carson, D.A. Role of IL-1 receptor-associated kinase-M (IRAK-M) in priming of immune and inflammatory responses by nitrogen bisphosphonates. Proc. Natl. Acad. Sci. USA 108, 11163-11168 (2011).
59. O'Garra, A, Barrat, F.J., Castro, A.G., Vicari, A & Hawrylowicz, C. Strategies for use of IL-10 or its antagonists in human disease. Immunol. Rev. 223, 114-131 (2008).
60. Santosuosso, M. et al. Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization. J. Immunol. 178, 2387-2395 (2007).
61. Santosuosso, M, Zhang, X, McCormick, S, Wang, J, Hitt, M & Xing, Z. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 Tcells within the airway lumen. J. Immunol. 174, 7986-7994 (2005).
62. Kugathasan, K, Roediger, E.K., Small, C.L., McCormick, S, Yang, P & Xing, Z. CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naive and antigen-primed T cells. BMC Immunol. 9, 48 (2008).
63. Xing, Z, Ohkawara, Y, Jordana, M, Graham, F & Gauldie, J. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J. Clin. Invest. 97, 1102-1110 (1996).